Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.
Chen Y, Li D, Li S. The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia. Cell Cycle. 2009 Nov 01; 8(21):3488-92.
View in:
PubMed
subject areas
5-Lipoxygenase-Activating Proteins
Animals
Benzamides
Carrier Proteins
Genes, abl
Humans
Hydroxyurea
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Lipoxygenase Inhibitors
Membrane Proteins
Mice
Mice, Knockout
Myeloproliferative Disorders
Neoplastic Stem Cells
Piperazines
Protein Kinase Inhibitors
Pyrimidines
authors with profiles
Shaoguang Li MD, PhD